UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 72

Sortiert nach

EGFR activation limits the response of liver cancer to lenvatinib

Nature (London), 2021-07, Vol.595 (7869), p.730-734

2021

Link zum Volltext

Verfügbarkeit prüfen

Phosphoglucomutase 1 inhibits hepatocellular carcinoma progression by regulating glucose trafficking

PLoS biology, 2018-10, Vol.16 (10), p.e2006483-e2006483

2018

Link zum Volltext

Verfügbarkeit prüfen

DNA hypermethylation modification promotes the development of hepatocellular carcinoma by depressing the tumor suppressor gene ZNF334

Cell death & disease, 2022-05, Vol.13 (5), p.446-446, Article 446

2022

Link zum Volltext

Verfügbarkeit prüfen

Laparoscopic right hemihepatectomy following a novel optimized portal vein embolization: a video case report

BMC gastroenterology, 2022-06, Vol.22 (1), p.284-284, Article 284

2022

Link zum Volltext

Verfügbarkeit prüfen

NQO1 promotes an aggressive phenotype in hepatocellular carcinoma via amplifying ERK‐NRF2 signaling

Cancer science, 2021-02, Vol.112 (2), p.641-654

2021

Link zum Volltext

Verfügbarkeit prüfen

The Prediction of Clinical Outcome in Hepatocellular Carcinoma Based on a Six-Gene Metastasis Signature

Clinical cancer research, 2017-01, Vol.23 (1), p.289-297

2017

Link zum Volltext

Verfügbarkeit prüfen

FTO promotes liver inflammation by suppressing m6A mRNA methylation of IL-17RA

Frontiers in oncology, 2022-09, Vol.12, p.989353-989353

2022

Link zum Volltext

Verfügbarkeit prüfen

Neuraminidase 1 (NEU1) promotes proliferation and migration as a diagnostic and prognostic biomarker of hepatocellular carcinoma

Oncotarget, 2016-10, Vol.7 (40), p.64957-64966

2016

Link zum Volltext

Verfügbarkeit prüfen

Minimally invasive surgery of malignancies: time to argue the fundamental reasons for this emerging technique

Hepatobiliary surgery and nutrition, 2020-04, Vol.9 (2), p.195-197

2020

Link zum Volltext

Verfügbarkeit prüfen

A retrospective study of the efficacy and safety of donafenib combined with TACE as adjuvant therapy in patients with high-risk recurrence factors after hepatocellular carcinoma surgery

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e16121-e16121

2023

Link zum Volltext

Verfügbarkeit prüfen

High-throughput sequencing approach for the identification of lncRNA biomarkers in hepatocellular carcinoma and revealing the effect of ZFAS1/miR-150-5p on hepatocellular carcinoma progression

PeerJ (San Francisco, CA), 2023-02, Vol.11, p.e14891, Article e14891

2023

Link zum Volltext

Verfügbarkeit prüfen

Impact of preoperative TACE on incidences of microvascular invasion and long‐term post‐hepatectomy survival in hepatocellular carcinoma patients: A propensity score matching analysis

Cancer medicine (Malden, MA), 2021-03, Vol.10 (6), p.2100-2111

2021

Link zum Volltext

Verfügbarkeit prüfen

肝细胞癌降期转化的治疗策略

临床肝胆病杂志, 2020-02, Vol.36 (2), p.252-257

2020

Link zum Volltext

Verfügbarkeit prüfen

Heat shock protein 90 promotes RNA helicase DDX5 accumulation and exacerbates hepatocellular carcinoma by inhibiting autophagy

Cancer biology & medicine, 2021-08, Vol.18 (3), p.693-704

2021

Link zum Volltext

Verfügbarkeit prüfen

Spatial multimodal analysis revealed tertiary lymphoid structures as a risk stratification indicator in combined hepatocellular-cholangiocarcinoma

Cancer letters, 2024-01, Vol.581, p.216513-216513, Article 216513

2024

Link zum Volltext

Verfügbarkeit prüfen

DANCR deletion retards the initiation and progression of hepatocellular carcinoma based on gene knockout and patient-derived xenograft in situ hepatoma mice model

Cancer letters, 2022-12, Vol.550, p.215930-215930, Article 215930

2022

Link zum Volltext

Verfügbarkeit prüfen

Double‐negative feedback loop between MicroRNA‐422a and forkhead box (FOX)G1/Q1/E1 regulates hepatocellular carcinoma tumor growth and metastasis

Hepatology (Baltimore, Md.), 2015-02, Vol.61 (2), p.561-573

2015

Link zum Volltext

Verfügbarkeit prüfen

EYA4 serves as a prognostic biomarker in hepatocellular carcinoma and suppresses tumour angiogenesis and metastasis

Journal of cellular and molecular medicine, 2019-06, Vol.23 (6), p.4208-4216

2019

Link zum Volltext

Verfügbarkeit prüfen

Dual Inhibition of CDK4/6 and XPO1 Induces Senescence With Acquired Vulnerability to CRBN-Based PROTAC Drugs

Gastroenterology (New York, N.Y. 1943), 2024-06, Vol.166 (6), p.1130-1144.e8

2024

Link zum Volltext

Verfügbarkeit prüfen

Development and comprehensive validation of a predictive prognosis model for very early HCC recurrence within one year after curative resection: a multicenter cohort study

International journal of surgery (London, England), 2024-06, Vol.110 (6), p.3401-3411

2024

Link zum Volltext

Verfügbarkeit prüfen

MiR-429 increases the metastatic capability of HCC via regulating classic Wnt pathway rather than epithelial–mesenchymal transition

Cancer letters, 2015-08, Vol.364 (1), p.33-43

2015

Link zum Volltext

Verfügbarkeit prüfen

Long Stress Induced Non-Coding Transcripts 5 (LSINCT5) Promotes Hepatocellular Carcinoma Progression Through Interaction with High-Mobility Group AT-hook 2 and MiR-4516

Medical science monitor, 2018-11, Vol.24, p.8510-8523

2018

Link zum Volltext

Verfügbarkeit prüfen

Retracted: NQO1 promotes an aggressive phenotype in hepatocellular carcinoma via amplifying ERK‐NRF2 signaling

Cancer science, 2021-02, Vol.112 (2), p.641-654

2021

Link zum Volltext

Verfügbarkeit prüfen

Genomic characterization of a large panel of patient-derived hepatocellular carcinoma xenograft tumor models for preclinical development

Oncotarget, 2015-08, Vol.6 (24), p.20160-20176

2015

Link zum Volltext

Verfügbarkeit prüfen

Sustained activation of EGFR-ERK1/2 signaling limits the response to tigecycline-induced mitochondrial respiratory deficiency in liver cancerResearch in context

EBioMedicine, 2023-01, Vol.87, p.104397

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 72

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(66)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(51)
Life Sciences & Biomedicine
(35)
Humans
(20)
Technology
(16)
Hepatocellular Carcinoma
(15)
Animals
(13)
Oncology
(13)
Liver Cancer
(12)
Physical Sciences
(11)
Engineering
(9)
Female
(9)
Liver Neoplasms - Pathology
(9)
Tumors
(9)
Carcinoma, Hepatocellular - Pathology
(8)
Mice
(8)
Prognosis
(8)
Carcinoma, Hepatocellular - Genetics
(7)
Liver Neoplasms - Genetics
(7)
Male
(7)
Patients
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

EGFR activation limits the response of liver cancer to lenvatinib

Phosphoglucomutase 1 inhibits hepatocellular carcinoma progression by regulating glucose trafficking

DNA hypermethylation modification promotes the development of hepatocellular carcinoma by depressing the tumor suppressor gene ZNF334

Laparoscopic right hemihepatectomy following a novel optimized portal vein embolization: a video case report

NQO1 promotes an aggressive phenotype in hepatocellular carcinoma via amplifying ERK‐NRF2 signaling

The Prediction of Clinical Outcome in Hepatocellular Carcinoma Based on a Six-Gene Metastasis Signature

FTO promotes liver inflammation by suppressing m6A mRNA methylation of IL-17RA

Neuraminidase 1 (NEU1) promotes proliferation and migration as a diagnostic and prognostic biomarker of hepatocellular carcinoma

Minimally invasive surgery of malignancies: time to argue the fundamental reasons for this emerging technique

A retrospective study of the efficacy and safety of donafenib combined with TACE as adjuvant therapy in patients with high-risk recurrence factors after hepatocellular carcinoma surgery

High-throughput sequencing approach for the identification of lncRNA biomarkers in hepatocellular carcinoma and revealing the effect of ZFAS1/miR-150-5p on hepatocellular carcinoma progression

Impact of preoperative TACE on incidences of microvascular invasion and long‐term post‐hepatectomy survival in hepatocellular carcinoma patients: A propensity score matching analysis

肝细胞癌降期转化的治疗策略

Heat shock protein 90 promotes RNA helicase DDX5 accumulation and exacerbates hepatocellular carcinoma by inhibiting autophagy

Spatial multimodal analysis revealed tertiary lymphoid structures as a risk stratification indicator in combined hepatocellular-cholangiocarcinoma

DANCR deletion retards the initiation and progression of hepatocellular carcinoma based on gene knockout and patient-derived xenograft in situ hepatoma mice model

Double‐negative feedback loop between MicroRNA‐422a and forkhead box (FOX)G1/Q1/E1 regulates hepatocellular carcinoma tumor growth and metastasis

EYA4 serves as a prognostic biomarker in hepatocellular carcinoma and suppresses tumour angiogenesis and metastasis

Dual Inhibition of CDK4/6 and XPO1 Induces Senescence With Acquired Vulnerability to CRBN-Based PROTAC Drugs

Development and comprehensive validation of a predictive prognosis model for very early HCC recurrence within one year after curative resection: a multicenter cohort study

MiR-429 increases the metastatic capability of HCC via regulating classic Wnt pathway rather than epithelial–mesenchymal transition

Long Stress Induced Non-Coding Transcripts 5 (LSINCT5) Promotes Hepatocellular Carcinoma Progression Through Interaction with High-Mobility Group AT-hook 2 and MiR-4516

Retracted: NQO1 promotes an aggressive phenotype in hepatocellular carcinoma via amplifying ERK‐NRF2 signaling

Genomic characterization of a large panel of patient-derived hepatocellular carcinoma xenograft tumor models for preclinical development

Sustained activation of EGFR-ERK1/2 signaling limits the response to tigecycline-induced mitochondrial respiratory deficiency in liver cancerResearch in context

Suchergebnisse filtern